Final 5-year outcomes of the TRIAS High Risk of Restenosis; a multi-centre, randomized trial comparing endothelial progenitor cell capturing stent with drug-eluting stents
Event:
ESC Congress 2019
Topic:
Stents
Session:
Percutaneous coronary syndrome: pharma and devices